Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
N/A
535,293 New
535,293 $369,000
Q3 2023

Nov 14, 2023

BUY
N/A
2,868 Added 17.41%
19,338 $13,000
Q2 2023

Aug 11, 2023

BUY
$0.0 - $0.69 $0 - $11,364
16,470 New
16,470 $11,000
Q4 2022

Feb 14, 2023

BUY
$0.24 - $0.4 $4,644 - $7,741
19,354 New
19,354 $4,000
Q2 2022

Aug 15, 2022

BUY
$0.26 - $0.37 $4,456 - $6,341
17,139 Added 94.23%
35,327 $11,000
Q1 2022

May 16, 2022

SELL
$0.31 - $0.41 $45,536 - $60,226
-146,893 Reduced 88.98%
18,188 $7,000
Q4 2021

Feb 14, 2022

BUY
$0.38 - $0.68 $62,730 - $112,255
165,081 New
165,081 $64,000
Q2 2021

Aug 11, 2021

SELL
$0.75 - $1.15 $19,004 - $29,139
-25,339 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$0.53 - $2.47 $13,429 - $62,587
25,339 New
25,339 $28,000
Q3 2020

Nov 16, 2020

SELL
$0.54 - $0.78 $7,248 - $10,470
-13,424 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$0.47 - $0.86 $37,131 - $67,942
-79,003 Reduced 85.48%
13,424 $7,000
Q1 2020

May 15, 2020

BUY
$0.53 - $0.99 $48,986 - $91,502
92,427 New
92,427 $49,000
Q4 2019

Feb 14, 2020

SELL
$0.3 - $0.69 $11,531 - $26,522
-38,439 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$0.31 - $0.42 $7,028 - $9,521
22,671 Added 143.78%
38,439 $12,000
Q2 2019

Aug 14, 2019

BUY
$0.37 - $0.47 $5,834 - $7,410
15,768 New
15,768 $6,000
Q4 2018

Feb 14, 2019

SELL
$0.27 - $0.52 $2,744 - $5,286
-10,166 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$0.43 - $1.07 $4,371 - $10,877
10,166 New
10,166 $5,000
Q2 2018

Aug 14, 2018

SELL
$0.39 - $0.55 $127,353 - $179,601
-326,548 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$0.4 - $0.49 $78,282 - $95,895
195,705 Added 149.57%
326,548 $137,000
Q4 2017

Feb 14, 2018

BUY
$0.39 - $0.55 $46,604 - $65,724
119,499 Added 1053.41%
130,843 $52,000
Q3 2017

Nov 14, 2017

BUY
$0.51 - $0.6 $5,785 - $6,806
11,344
11,344 $6,000

Others Institutions Holding ISR

About Isoray, Inc.


  • Ticker ISR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 142,112,992
  • Market Cap $98.1M
  • Description
  • Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...
More about ISR
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.